Concepedia

Camlin Tierney

CT

Statistics

Publications

48

Citations

3.8K

H-Index

25

Active since

1990

Affiliations

Harvard University(Current)

Cancer Research And Biostatistics

Brigham and Women's Hospital

Harbor–UCLA Medical Center

The Lundquist Institute

Camlin Tierney is an author at Harvard University specializing in antiretroviral therapy, antiviral therapy, and human immunodeficiency virus pharmacotherapy.

Publications per year

1990–2025

48

Publications

48

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

David W. Haas, Heather J. Ribaudo, Richard B. Kim et al. · PubMed · 2004 · 629 citations

, , +17

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

Grace A. McComsey, Douglas Kitch, Eric S. Daar et al. · The Journal of Infectious Diseases · 2011 · 497 citations · Full text

, , +16

Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS)

David K. Ahern, Larry Gorkin, Jeffrey L. Anderson et al. · The American Journal of Cardiology · 1990 · 436 citations

, , +16

Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

Paul E. Sax, Camlin Tierney, Ann C. Collier et al. · New England Journal of Medicine · 2009 · 316 citations · Full text

, , +16

Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B

Gonzague Jourdain, Nicole Ngo‐Giang‐Huong, Linda Harrison et al. · New England Journal of Medicine · 2018 · 284 citations

, , +16

1–5 of 48